NCT06982313 2026-03-11
Babytam long
Ente Ospedaliero Ospedali Galliera
Completed
Clinical Trials
17 trialsNCT00667121 2025-02-14
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Completed
NCT06154590 2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
NCT05801705 2023-05-18
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT05800197 2023-04-06
NEMO
Blokhin's Russian Cancer Research Center
Unknown
NCT05131893 2021-11-23
Neoadjuvant Treatment of Breast Cancer
National Institute of Oncology, Hungary
Not yet recruiting
NCT04852081 2021-04-21
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center
Unknown
NCT04666805 2020-12-14
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University
Unknown
NCT04116827 2019-10-07
Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
Samsung Medical Center
Unknown
NCT03582865 2019-07-08
Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Assiut University
Unknown
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT00873366 2018-01-23
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
Mayo Clinic
Terminated
NCT00900744 2017-08-25
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Icahn School of Medicine at Mount Sinai
Completed
NCT00899197 2017-08-01
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Wake Forest University Health Sciences
Terminated
NCT01896050 2016-06-28
LOGRIBMET
University of Michigan Rogel Cancer Center
Completed
NCT01169792 2010-07-26
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
Yonsei University
Completed
NCT00973037 2009-09-09
ASTRRA-CYP2D6
Korea University Anam Hospital
Unknown